| Host: |
Rabbit |
| Applications: |
WB/IHC/IF/ELISA |
| Reactivity: |
Human/Mouse |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-Beta-sarcoglycan (87-136 aa) is suitable for use in Western Blot, Immunohistochemistry, Immunofluorescence and ELISA research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
| Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Concentration: |
1 mg/mL |
| Dilution Range: |
WB 1:500-1:2000IHC 1:100-1:300ELISA 1:40000IF 1:50-200 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
SGCB |
| Gene ID: |
6443 |
| Uniprot ID: |
SGCB_HUMAN |
| Immunogen Region: |
87-136 aa |
| Specificity: |
Sarcoglycan-Beta Polyclonal Antibody detects endogenous levels of Sarcoglycan-Beta protein. |
| Immunogen: |
The antiserum was produced against synthesized peptide derived from the human Sarcoglycan-beta at the amino acid range 87-136 |
| Post Translational Modifications | Disulfide bonds are present. |
| Function | Component of the sarcoglycan complex, a subcomplex of the dystrophin-glycoprotein complex which forms a link between the F-actin cytoskeleton and the extracellular matrix. |
| Protein Name | Beta-SarcoglycanBeta-Sg43 Kda Dystrophin-Associated Glycoprotein43dagA3b |
| Cellular Localisation | Cell MembraneSarcolemmaSingle-Pass Type Ii Membrane ProteinCytoplasmCytoskeleton |
| Alternative Antibody Names | Anti-Beta-Sarcoglycan antibodyAnti-Beta-Sg antibodyAnti-43 Kda Dystrophin-Associated Glycoprotein antibodyAnti-43dag antibodyAnti-A3b antibodyAnti-SGCB antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
